The pneumococcal cell envelope stress-sensing system LiaFSR is activated by murein hydrolases and lipid II-interacting antibiotics.

Journal of Bacteriology
Vegard EldholmLeiv S Håvarstein

Abstract

In the Firmicutes, two-component regulatory systems of the LiaSR type sense and orchestrate the response to various agents that perturb cell envelope functions, in particular lipid II cycle inhibitors. In the current study, we found that the corresponding system in Streptococcus pneumoniae displays similar properties but, in addition, responds to cell envelope stress elicited by murein hydrolases. During competence for genetic transformation, pneumococci attack and lyse noncompetent siblings present in the same environment. This phenomenon, termed fratricide, increases the efficiency of horizontal gene transfer in vitro and is believed to stimulate gene exchange also under natural conditions. Lysis of noncompetent target cells is mediated by the putative murein hydrolase CbpD, the key effector of the fratricide mechanism, and the autolysins LytA and LytC. To avoid succumbing to their own lysins, competent attacker cells must possess a protective mechanism rendering them immune. The most important component of this mechanism is ComM, an integral membrane protein of unknown function that is expressed only in competent cells. Here, we show that a second layer of self-protection is provided by the pneumococcal LiaFSR system, which ...Continue Reading

References

Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J L BrissetteP Model
Nov 21, 1995·Proceedings of the National Academy of Sciences of the United States of America·L S HåvarsteinD A Morrison
Dec 29, 1995·Gene·A M Guérout-FleuryP Stragier
Aug 1, 1996·Molecular Microbiology·L S HåvarsteinD A Morrison
Oct 27, 2001·Applied and Environmental Microbiology·C K SungD A Morrison
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Hilde SteinmoenLeiv Sigve Håvarstein
May 27, 2003·Trends in Biochemical Sciences·Daniel J RigdenMichael Y Galperin
May 27, 2003·Trends in Biochemical Sciences·Alex Bateman, Neil D Rawlings
Apr 22, 1960·Biochimica Et Biophysica Acta·S LACKS, R D HOTCHKISS
Dec 4, 2003·Molecular Microbiology·Thorsten MascherJohn D Helmann
Jun 3, 2004·Genome Research·Gavin E CrooksSteven E Brenner
Jul 27, 2004·Antimicrobial Agents and Chemotherapy·Thorsten MascherJohn D Helmann
Nov 13, 2004·FEMS Microbiology Reviews·Rubens López, Ernesto García
Jun 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Sébastien GuiralJean-Pierre Claverys
Jun 22, 2005·Journal of Bacteriology·Louise KausmallyLeiv Sigve Håvarstein
Jul 7, 2005·Genome Research·Eric J AlmAdam P Arkin
Jul 28, 2005·Molecular Microbiology·Andrew J Darwin
Nov 18, 2005·Journal of Bacteriology·Wolfgang HaasElaine I Tuomanen
Jan 25, 2006·Molecular Microbiology·Leiv Sigve HåvarsteinJean-Pierre Claverys
Sep 29, 2006·Antimicrobial Agents and Chemotherapy·S GardeteA Tomasz
Mar 3, 2007·FEMS Microbiology Letters·Alexander HalfmannReinhold Brückner
May 9, 2007·The Journal of Biological Chemistry·Patrick VeigaSaulius Kulakauskas
Jan 5, 2008·FEMS Microbiology Reviews·Sina JordanThorsten Mascher
Mar 3, 2009·Journal of Bacteriology·Prashanth SuntharalingamDennis G Cvitkovitch

❮ Previous
Next ❯

Citations

Sep 9, 2011·The New England Journal of Medicine·Cesar A AriasGeorge M Weinstock
Mar 20, 2013·Antimicrobial Agents and Chemotherapy·Jose M MunitaCesar A Arias
Jul 20, 2010·Journal of Bacteriology·Diana WolfThorsten Mascher
Dec 1, 2011·Environmental Microbiology Reports·Miriam MoscosoErnesto García
Aug 29, 2013·Molecular Microbiology·Anthony W KingstonJohn D Helmann
May 11, 2016·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Hwang-Soo JooMichael Otto
Jul 5, 2016·Frontiers in Cell and Developmental Biology·Rafi RashidKimberly A Kline
May 29, 2015·PloS One·Manoharan ShankarIndranil Biswas
Oct 19, 2016·Current Opinion in Microbiology·Truc T TranCesar A Arias
Jul 29, 2016·Microbiology and Molecular Biology Reviews : MMBR·Konstantinos PapadimitriouJan Kok
Jan 29, 2020·Infection and Immunity·Lamar Thomas, Laura Cook
Mar 20, 2020·Molecular Microbiology·Tridib GangulyJosé A Lemos
Mar 20, 2019·Journal of Bacteriology·Jelle SlagerJan-Willem Veening
Nov 5, 2020·Scientific Reports·Jessica L BradshawLarry S McDaniel
Mar 28, 2021·Journal of Applied Microbiology·P S Lannes-CostaP E Nagao
Sep 22, 2021·MBio·Dhriti SinhaNicholas R De Lay

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.